# Inflammatory mediators and NSAID effects

{
  "id": "T10678",
  "title": "Inflammatory mediators and NSAID effects",
  "url": "/topics/T10678",
  "kind": "topic-directory",
  "aeo_cohort": "topic-directory",
  "provider": "openalex",
  "revision": "ee8a2692ed402993",
  "catalogue_revision": "f050b5d4780b1289",
  "numeric_address": "36240215723878818",
  "address_version": "morton4x16-v1",
  "coordinates": [
    4,
    27,
    2736,
    10678
  ],
  "answer_status": "Directory metadata; local answer requires separate source review",
  "truth_status": "Subject descriptor, not a factual answer or a demonstrated knowledge gap"
}

This cluster of papers focuses on the use of cyclooxygenase-2 (COX-2) inhibitors, such as rofecoxib, celecoxib, and naproxen, in the context of inflammation and cancer. It explores the gastrointestinal and cardiovascular toxicity, chemopreventive effects, and potential risks associated with these drugs. The cluster also delves into the molecular biology of prostaglandins, particularly prostaglandin E2, and their role in modulating immune responses and promoting cancer growth.

Directory metadata is not a factual answer or evidence of a global knowledge gap.

Source: https://openalex.org/T10678

No owner-reviewed local answer yet.